Athenex Inc. (ATNX) Fundamentals

Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell receptor-engineered T-cells, and arginine deprivation therapy technology platforms. It is primarily engaged in conducting research and development activities through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting preclinical and clinical testing, recruiting personnel, identifying and evaluating additional drug candidates for potential in-licensing or acquisition, and raising capital to support development and commercialization activities.
SHARE INFORMATION
Market Cap$ 28,743,084
Shares Outstanding157,410,098
Float121,851,955
Percent Float77.41%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 120,181,000
Latest Fiscal EPS$ -1.92
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions232
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months8,621,939
Institutional Holdings Percent42.4%
Institutional Sold Previous 3 Months15,355,541
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months742,632
Insider Holdings Percent5.3
Insider Sold Previous 3 Months-
Insider Shares Owned8,393,508
TRADING INFO
52 Week High$ 1.20
52 Week Low$ 0.12
52 Week High Change$ -82.10
21 Day Moving Average$ 0.1805
21 Day Extended Moving Average$ 0.180006
50 Day Moving Average$ 0.1754
50 Day Extended Moving Average$ 0.18867
200 Day Moving Average$ 0.379581
200 Day Extended Moving Average$ 0.58882
10 Day Average Volume1,129,488
20 Day Average Volume1,616,083
30 Day Average Volume7,079,862
50 Day Average Volume4,711,747
Alpha-0.059662
Beta1.1925
Standard Deviation0.207772
R20.095790
7 Day Price Change$ -0.0049
7 Day Percent Change-2.61%
21 Day Price Change$ 0.0077
21 Day Percent Change4.4%
30 Day Price Change$ 0.0351
30 Day Percent Change23.8%
Month to Date Price Change$ 0.0351
Month to Date Percent Change23.8%
Quarter to Date Price Change$ 0.0351
Quarter to Date Percent Change23.8%
180 Day Price Change$ -0.3244
180 Day Percent Change-63.98%
200 Day Price Change$ -0.4109
200 Day Percent Change-69.23%
Year to Date Price Change$ 0.0351
Year to Date Percent Change23.8%

Athenex Inc. (ATNX) Key Ratios

PROFITABILITY
EBIT Margin-128.9%
EBITDA Margin-125.7%
Pre-Tax Profit Margin-229.5%
Profit Margin Count-77.71%
Gross Margin21.4%
Profit Margin TOT-74.51%
INCOME STATEMENTS
Revenue$ 94,188,000
Revenue Per Share$ 0.5984
Revenue (3 Years)$ -0.95
Revenue (5 Years)$ 21.16
FINANCIAL STRENGTH
Price to Tangible Book-0.60
Total Debt To Equity1.70
Int Coverage-7.90
Current Ratio1.50
Leverage Ratio9.30
Quick Ratio0.80
Long Term Debt To Capital0.51
VALUATION MEASURES
PE Ratio-0.10
Enterprise Value$ 34,759,558
Price to Sales0.305167
Price to Free Cash-0.50
PE High Last 5 Years-8.40
Price To Book1.10
Price To Cash Flow0.00
PE Low Last 5 Years-4.90
Price to Tangible Book-0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.40
Invoice Turnover2.70
Assets Turnover0.40
Return Assets-62.54
Return on Equity-226.22
Return on Capital-85.62

Athenex Inc. (ATNX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOJohnson Y.N. Lau
Emplyoees666
Last AuditUE
CIK0001300699
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1001 Main Street
Suite 600
Buffalo, NY 14203
Websitehttps://www.athenex.com
Facsimile+1 716 800-6816
Telephone+1 716 427-2950
Emailrandollsze@athenex.com
Your Recent History
NASDAQ
ATNX
Athenex
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230202 08:37:07